FDA inspection
Glaxo Wellcome Manufacturing Pte Limited: FDA inspection ending Mar 13, 2009
FDA inspection 572094 · No Action Indicated (NAI) · Singapore
Key facts
| Inspection ID | 572094 |
|---|---|
| Firm | Glaxo Wellcome Manufacturing Pte Limited |
| FEI number | 3002807079 |
| Address | Pioneer Sector 1 |
| City | Singapore |
| Country | Singapore |
| Fiscal year | 2009 |
| Inspection end date | Mar 13, 2009 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data